Список литературы

    1. ААО Guidelines AMD, 2010. www.aao.org.

    2. American Academy of Ophthalmology Preferred Practice Patterns Committee. Preferred Practice Pattern® Guidelines. Comprehensive Adult Medical Eye Evaluation. San Francisco, CA: AAO; 2005. Available at: http://www.aao.org/ppp.

    3. Klein R., Klein B. E., Tomany S. C. et al. Ten — year incidence and progression of age — related maculopathy: The Beaver Dam Eye Study. Ophthalmology 2002; Vol.109:1767–1779.

    4. А.С. Измайлов. Новые методы диагнос

    5. Нероев В.В. Российское наблюдательное эпидемиологическое неинтервенционное исследование пациентов с влажной формой возрастной макулярной дегенерации. Российский офтальмологический журнал 2011; 2:4–9.

    6. Khan J. C., Thurlby D. A., Shahid H. et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularization. Br J Ophthalmol.2006; Vol.90: 75–80.

    7. The Age — Related Eye Disease Study Research Group. A randomized, placebocontrolled, clinical trial of supplementation with vitamins C and E and beta — carotene for age related cataract and vision loss: AREDS report number 9. Arch. Ophthalmol., 2001;Vol. 119:1439–1452.

    8. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age — related macular degeneration. Arch. Ophthalmol. 1993; Vol. 111: 1200–1209.

    9. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five — year results from randomized clinical trials. Arch. Ophthalmol.1994; Vol. 112: 500–509.

    10. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five — year results from randomized clinical trials. Arch Ophthalmol.1991; Vol. 109:1109–1114.